portfolio rebalancing

Crescent Grove Advisors sold $5.4M stake in ultrashort bond ETF $UYLD, trimming position by 30% amid potential Fed rate-cut signals.

Portfolio rebalancing should respond to material life changes rather than calendar dates, balancing discipline benefits against tax costs and individual circumstances.

Florin Court Capital sold $3.64M of clean energy ETF shares in Q1 2026 after 84% surge, but maintains it as largest holding at 18.5%.

Marqeta director sold half his stake ($78K) in April transaction; analysts note insider sales typically reflect personal planning, not company concerns.

Schwallier Wealth Management slashed its Treasury ETF position by 85% in Q1 2026, reducing exposure from 5.4% to 0.88% of assets, signaling strategic shift on interest rates.

Darwin Wealth Management sold $3.5M worth of underperforming QQEW shares in Q1 2026, citing 16-point S&P 500 underperformance and weak 5.2% annual returns.

Financial advisors recommend post-tax season portfolio reviews, rebalancing overweighted positions, and maximizing retirement contributions through IRAs and 401(k)s.

Market breadth deterioration, seasonal weakness, midterm election volatility, and geopolitical tensions create elevated correction risk heading into summer 2026.

Sionna director sells $2.5M in stock (2% of holdings) during 215% surge; $310M cash position supports pipeline through 2028.

Capital Asset Advisory reduced its $VTC stake by $6.96 million, trimming its position from 2.5% to 2.1% of AUM in routine portfolio rebalancing.

Warren Buffett sold 75% of Berkshire's Apple stake in 2024-2025, redirecting proceeds to Chubb insurance and higher-yielding Treasuries.

MRA Advisory Group sold $5.35 million in QQQE shares, reducing its position from fourth to tenth-largest holding amid underperformance versus S&P 500.

Stewardship Advisors sold $7.6M of treasury ETF $GOVI in Q1, continuing an 87% position reduction over two quarters amid duration concerns.

Kopp Family Office exits $3.5M Viridian stake as stock plummets 50% following disappointing Phase 3 data and Amgen's superior competing results.

SNS Financial sold $5.88M of Invesco BulletShares 2026 ETF ahead of December fund termination, strategically reducing position to 2.53% of AUM.

Community Trust & Investment Company adds 122,541 shares of Community Trust Bancorp, increasing stake to 2.09M shares worth $126.79M amid strong 45.8% annual gains.

Market Street Wealth Management increased DFGX holdings by $3.5M, raising position to $37.62M (5.93% of AUM), representing 9.7% quarterly growth.

Biotech hedge fund BVF Partners sold $63M in MoonLake shares, trimming its stake 78% while retaining 15.9M shares, amid broader sector volatility.

NVIDIA, Tesla, Rivian, and Nike face rising risks in Q2 2026 due to elevated valuations, operational challenges, and margin pressures.

Buffett exits half his BofA stake while deploying $1.2B into surging Chevron in his final CEO quarters, signaling skepticism on financials and renewed energy conviction.